- - oalib

OALib Journal期刊
ISSN: 2333-9721
费用：99美元

投递稿件

为什么选择我们？ >>

- 开源期刊

- 同行审议

- 快速出刊

- 终身存储

- 免费检索

- 免费推广

- 更多...

- 搜索引擎

Multiple Sclerosis Journal

ISSN Print: 2055-2173

ISSN Online: 2055-2173

主页: https://journals.sagepub.com/loi/msoa

分享:

The association between handedness and clinicodemographic characteristics in people with multiple sclerosis: a brief report

Afsaneh Shirani,Anne H Cross,Robert T Naismith,null

The Multiple Sclerosis Severity Score: fluctuations and prognostic ability in a longitudinal cohort of patients with MS

AE Miller,C Farrell,RH Gross,SC Krieger,SH Sillau

Does attendance at the ECTRIMS congress impact on therapeutic decisions in multiple sclerosis care?

Angel P Sempere,Gustavo Saposnik,Jorge Maurino,Maria A Terzaghi,Maria Pia Amato,Xavier Montalban

Distinct serum and cerebrospinal fluid cytokine and chemokine profiles in autoantibody

Alberto Gajofatto,Carmen Schwaiger,Chiara R Mancinelli,Florian Deisenhammer,Kevin Rostasy,Livia S Hofer,Markus Reindl,Rachele Delogu,Romana H？ftberger,Salvatore Monaco,Sara Mariotto,Sebastian Wurth,Sergio Ferrari,Thomas Berger

Inflammatory activity and vitamin D levels in an MS population treated with rituximab

Anders Svenningsson,Gabriel Gran？sen,Johan Linden,Jonatan Salzer,Peter Sundstr？m

The Multiple Sclerosis Functional Composite and Symbol Digit Modalities Test as outcome measures in pediatric multiple sclerosis

Emma Woolbright,Hitoshi Koshiya,J. Nicholas Brenton,Myla D. Goldman

Perception of stigma in patients with primary progressive multiple sclerosis

Antonio García-Merino,Bonaventura Casanova-Estruch,Daniel Prefasi,Francisco Gascón,Francisco Pérez-Miralles,Guillermo Izquierdo,Jorge Maurino,José R Ara,Lluis Ramió-Torrentà,Lucienne Costa-Frossard,María L Martínez-Ginés,Sara Moreno-García,Virginia Meca-Lallana,óscar Fernández

Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments

Flavia Nelson,J William Lindsey,Staley A Brod

The FLUENT study design: investigating immune cell subset and neurofilament changes in patients with relapsing multiple sclerosis treated with fingolimod

Amit Bar-Or,Ann Jannu,Barry Singer,Bruce A C Cree,Jeffrey A Cohen,May H Han,Ryan C Winger,Scott Kolodny,Xiangyi Meng,Yang Mao-Draayer

Use and cost of disease

Helene T Machado,Jonathan S Levin,Lisa I Iezzoni,Meredith B Rosenthal,R Philip Kinkel,Sarah L Minden

Advanced imaging findings in progressive solitary sclerosis: a single lesion or a global disease?

Adam Soares,Anthony L Traboulsee,B Mark Keegan,David Clayton,Emilie Nevill,Erin L MacMillan,Hideki Garren,Irene M Vavasour,Jillian K Chan,Lisa Eunyoung Lee,Robert L Carruthers,Roger Tam,Shannon H Kolind

Cross

Bonnie I Glanz,Brian C Healy,Cindy T Gonzalez,Dorlan J Kimbrough,Howard Weiner,Maria Assunta Rocca,Massimo Filippi,Mattia Rosso,Tanuja Chitnis

Effect of different doses of gadolinium contrast agent on clinical outcomes in MS

Anthony L Traboulsee,Carolyn Taylor,David KB Li,Heejun Kang,Mark S Freedman,Nathalie Ackermans,Robert Carruthers,Roger Tam,Shannon Kolind

Costs of illness progression for different multiple sclerosis phenotypes: a population

Andrius Kavaliunas,Chantelle Murley,Emilie Friberg,Hanna Gyllensten,Jan Hillert,Kristina Alexanderson,Petter Tingh？g

Conversion of clinically isolated syndrome to multiple sclerosis: a prospective multi

A Chatterjee,A Das,A Datta,A Ghosh,A Haldar,A Hazra,A Mukherjee,D Choudhury,E Ghosh,M Saha,S Ojha,S Purakayastha,SS Nandi,TK Banerjee

Patients transitioning from non

Barry Hendin,Bj？rn Sperling,Brian Werneburg,DeRen Huang,Fiorenza Gaudenzi,Monica Mann,Qunming Dong,Robert T Naismith,Sibyl Wray

No differential gene expression for CD4+ T cells of MS patients and healthy controls

Anna Eriksson,Elisabeth G Celius,Hanne F Harbo,Ina S Brorson,Ingvild S Leikfoss,Lisa F Barcellos,P？l Berg-Hansen,Steffan D Bos,Tone Berge

Oral lipoic acid as a treatment for acute optic neuritis: a blinded, placebo controlled randomized trial

Allison Fryman,Charles F Murchison,Dennis N Bourdette,Gail H Marracci,Julie Falardeau,Lindsey Wooliscroft,Michele Mass,Rohan Wanchu,Vijayshree Yadav,William L Hills

Predictors of hospital

Alessio Signori,Cristina Grosso,Davide Cattaneo,Elisabetta Groppo,Loredana La Mantia,Marco Rovaris,Maria Pia Sormani

Initiating disease

A Solari,DD Wilkie,R Nicholas

Reviewer's List, 2019

null

Subjective cognitive concern in multiple sclerosis is associated with reduced thalamic and cortical gray matter volumes

Brooke Valdez,Enrique Alvarez,Isaiah Kletenik,Justin M Honce,Luis D Medina,Timothy L Vollmer

Efficacy and safety of dimethyl fumarate in treatment

André Matta,Jang Yun,Katsutoshi Hiramatsu,Masahiro Mori,Masakazu Hase,Shinichi Torii,Takashi Ohashi,Yasuhiro Onizuka

Reducing return of disease activity in patients with relapsing multiple sclerosis transitioned from natalizumab to teriflunomide: 12

Chiayi Chen,James Thomas,Jessica Siuta,Judy O’Connor,Kateri J Spinelli,Keith Edwards,Kiren Kresa-Reahl,Kyle Smoot,Lindsay Lucas,Lore Garten,Stanley L Cohan,Tiffany Gervasi-Follmar,Vineetha Kamath

Cognitive function predicts work disability among multiple sclerosis patients

Andrius Kavaliunas,Emilie Friberg,Jan Hillert,Kristina Alexanderson,Petter Tingh？g,Tomas Olsson,Virginija Danylaite Karrenbauer

Multicentre assessment of motor and sensory evoked potentials in multiple sclerosis: reliability and implications for clinical trials

Christian Schindler,Fran？ois Jacques,Habib Bousleiman,Letizia Leocani,Martin Hardmeier,Peter Fuhr,Philipp Albrecht

Exploratory MRI measures after intravenous autologous culture

Daniel Ontaneda,Elizabeth Fisher,Erik Offerman,Jeffrey A Cohen,Jenny Feng,Jian Lin,Ken Sakaie,Kunio Nakamura,Mark Lowe,Sarah M Planchon

Preferences for exercise among black individuals with multiple sclerosis

Dominique Kinnett-Hopkins,Robert Motl

Myelin status is associated with change in functional mobility following slope walking in people with multiple sclerosis

D Backus,EM King,M Hoque,MJ Sabatier,MR Borich,TM Kesar

A randomised, controlled clinical trial of narrowband UVB phototherapy for clinically isolated syndrome: The PhoCIS study

Allan G Kermode,Anderson P Jones,Catherine d’Este,David R Booth,Judith M Cole,Lilian Cha,Marzena J Fabis-Pedrini,Matthew N Cooper,Prue H Hart,Robyn M Lucas,Scott N Byrne,Sian Geldenhuys,Stephanie Trend,William M Carroll

Serum heat shock protein 70 levels as a biomarker for inflammatory processes in multiple sclerosis

Bernhard Hemmer,Dorothea Buck,Gabriele Multhoff,Lisa Sick,Patricia Lechner

Patient

Devon S Conway,Kaila N Parker,Maria Cecilia Vieira,Nicolas R Thompson,Robert J Fox,Xiangyi Meng

A real

Amy L Phillips,Chris M Kozma,James D Bowen,Megan M Grosso

Factors associated with time from first

Andrew Chan,Anke Salmen,Caroline Pot,Christian P Kamm,Claudio Gobbi,Jens Kuhle,Jürg Kesselring,Marco Kaufmann,Milo A Puhan,Nina Steinemann,Pasquale Calabrese,Stephanie Rodgers,Viktor von Wyl,null

Contactin

Charlotte E Teunissen,Christian Enzinger,Franz Fazekas,Hugo Vrenken,Inge MW Verberk,Joep Killestein,Madhurima Chatterjee,Marleen JA Koel-Simmelink,Michael Khalil,Stefan Ropele

Monitoring cognitive change in multiple sclerosis using a computerized cognitive battery

A Van der Walt,D Darby,D Merlo,EJ Grobbee,H Butzkueven*,J Gale,J Haartsen,L De Meijer,O Skibina,P Maruff

Can a stress management programme reduce stress and improve quality of life in people diagnosed with multiple sclerosis?

Amanda Lydon,Jeannette Lechner-Scott,Rodney Lea,Sally Shaw,Sheila Mortimer-Jones,Susan Agland

Improved cognitive performance and event

Bianca Weinstock-Guttman,David W Shucard,Janet L Shucard,Ralph HB Benedict,Thomas J Covey

A randomized study to evaluate the effect of exercise on fatigue in people with relapsing–remitting multiple sclerosis treated with fingolimod

A Tallner,C Hentschke,K Pfeifer,K Schuh,M Baier,M M？urer,R Streber,S Seibert

Prolonged

Adrian Schembri,Avi Nativ,Chantal Paquette,Fran？ois Jacques,Pawel Kalinowski

Real

Charlotte Sharples,Gordon Mazibrada,Ines Perfect

Objective and subjective measures of dalfampridine efficacy in clinical practice

Colleen Farrell,Fred D Lublin,Joshua Friedman,Rebecca Farber,Stephen Krieger,Sylvia Klineova

Cladribine: Off

Benjamin P Turner,Christo Albor,César álvarez-Gonzalez,David Baker,Derek Soon,Gabriel Doctor,Gavin Giovannoni,George Pepper,Joela Mathews,Klaus Schmierer,Monica Marta,Ozlem Yildiz,Stefania De Trane,Zhifeng Mao

Addressing the targeting range of the ABILHAND

Carmen Castrillo-Viguera,Diego Cadavid,Farrah Pompilus,Jennifer Petrillo,Kiren Kresa-Reahl,Myla D Goldman,Patrick Marquis,Sara Strzok,Shih-Yin Chen,Sophie Cleanthous,Stanley Cohan,Stefan Cano

Feasibility of mesenchymal stem cell culture expansion for a phase I clinical trial in multiple sclerosis

Basabi Maitra,Brittney M Hooper,Hillard M Lazarus,Jane Reese Ko？,Jeffrey A Cohen,Karen T Lingas,Kylie M Drake,Micheala A Aldred,Peter B Imrey,Robert M Fox,Sarah M Planchon

No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta

Amit Bar-Or,Anthony Traboulsee,Douglas L Arnold,Eva Havrdová,Fred Lublin,Gavin Giovannoni,Giancarlo Comi,Hans-Peter Hartung,Hideki Garren,Iain Bennett,Jian Han,Julie Napieralski,Krzysztof Selmaj,Laura Julian,Ludwig Kappos,Regine Buffels,Shibeshih Belachew,Stephen L Hauser

Clinical efficacy of teriflunomide over a fixed 2

Julia Morawski,Karthinathan Thangavelu,Mark S Freedman

Novel computer

Andrew D Goodman,Andrew D Smith,Charles Duffy

High prevalence and indexes of anti

Adrian Wong,Alexander Lau,Allan Kermode,Angel Ng,Bonaventure Ip,Cheryl Au,Karen Ma,Lisa Au,Sze-Ho Ma,Vincent Mok,Wei Qiu

©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705